Geron Corporation granted stock options to Harout Semerjian upon his acceptance of employment on August 9, 2025.
4 reports, 1 independent
Updated Jul 14
Gone quiet
- Reports
- 4
- Developments
- 1
- Repetition
- 75%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Geron Corporation granted stock options to Harout Semerjian upon his acceptance of employment on August 9, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Geron Corporation
company
Nothing else this week.
Coverage
Newest first; wire copies grouped- Business WireGeron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) FOSTER CITY, Calif., August 08, 2025--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial stage biopharmace
- Business WireGeron Corporation Reports Second Quarter 2025 Financial Results and Recent Business Highlights Seasoned Commercial Hematology and Oncology Leader Harout Semerjian Appointed as President and CEO Achie